Guliana JM - Search Results

1

Results of long-term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinoma.

Modigliani E, Cohen R, Joannidis S, Siame-Mourot C, Guliana JM, Charpentier G, Cassuto D, Bentata Pessayre M, Tabarin A, Roger P, et al. Modigliani E, et al. Among authors: guliana jm. Clin Endocrinol (Oxf). 1992 Feb;36(2):183-6. doi: 10.1111/j.1365-2265.1992.tb00955.x. Clin Endocrinol (Oxf). 1992. PMID: 1568350

2

[Effects of subcutaneous administration of sandostatine (SMS 201.995) in 18 cases of thyroid medullary cancer].

Modigliani E, Guliana JM, Maroni M, Guillausseau JP, Chabrier G, Dupont JL, Caron J, Roger P, Bentata Pessayre M, Jacob C, et al. Modigliani E, et al. Among authors: guliana jm. Ann Endocrinol (Paris). 1989;50(6):483-8. Ann Endocrinol (Paris). 1989. PMID: 2635843 French.

3

Effects of short-term subcutaneous administration of SMS 201-995 on calcitonin plasma levels in patients suffering from medullary thyroid carcinoma.

Guliana JM, Guillausseau PJ, Caron J, Siame-Mourot C, Calmettes C, Modigliani E. Guliana JM, et al. Horm Metab Res. 1989 Oct;21(10):584-6. doi: 10.1055/s-2007-1009294. Horm Metab Res. 1989. PMID: 2807148 No abstract available.

4

Effect of a somatostatin analog (SMS 201-995) in perfusion on basal and pentagastrin-stimulated calcitonin levels in medullary thyroid carcinoma.

Modigliani E, Chayvialle JA, Cohen R, Perret G, Guliana JM, Vassy R, Roger P, Siame-Mourot C, Bennet M, Bentata-Pessayre M, et al. Modigliani E, et al. Among authors: guliana jm. Horm Metab Res. 1988 Dec;20(12):773-5. doi: 10.1055/s-2007-1010946. Horm Metab Res. 1988. PMID: 2906036 No abstract available.

5

The intratumoral immunoassayable somatostatin concentration is frequently elevated in medullary thyroid carcinoma. Results in 34 cases.

Modigliani E, Alamowitch C, Cohen R, Calmettes C, Guliana JM, Franc B, Bernard C, Chayvialle JA. Modigliani E, et al. Among authors: guliana jm. Cancer. 1990 Jan 15;65(2):224-8. doi: 10.1002/1097-0142(19900115)65:2<224::aid-cncr2820650208>3.0.co;2-y. Cancer. 1990. PMID: 1967221

6

[Tumor markers of medullary cancer of the thyroid body. Basic and endocrine aspects].

Guliana JM, Modigliani E. Guliana JM, et al. Ann Endocrinol (Paris). 1988;49(1):34-50. Ann Endocrinol (Paris). 1988. PMID: 2900620 Review. French.

7

[Detection and prognosis of medullary cancer of the thyroid gland. Influence of national multidisciplinary cooperation].

Guliana JM, Modigliani E, Guillausseau PJ, Aubert P, Milhaud G, Moukhtar MS, Calmettes C. Guliana JM, et al. Presse Med. 1989 Mar 11;18(10):521-4. Presse Med. 1989. PMID: 2523043 French.

8

Calcitonin receptor mRNA is expressed in human medullary thyroid carcinoma.

Frendo JL, Delage-Mourroux R, Cohen R, Pichaud F, Pidoux E, Guliana JM, Jullienne A. Frendo JL, et al. Among authors: guliana jm. Thyroid. 1998 Feb;8(2):141-7. doi: 10.1089/thy.1998.8.141. Thyroid. 1998. PMID: 9510122

9

Calcitonin receptor mRNA expression in TT cells: effect of dexamethasone.

Frendo JL, Delage-Mourroux R, Cohen R, Pichaud F, Pidoux E, Guliana JM, Jullienne A. Frendo JL, et al. Among authors: guliana jm. Mol Cell Endocrinol. 1998 Apr 30;139(1-2):37-43. doi: 10.1016/s0303-7207(98)00075-6. Mol Cell Endocrinol. 1998. PMID: 9705072

10

PCR amplification of CGRP II mRNA. Variable expression in tumoral and non-tumoral human thyroid.

Lasmoles F, Minvielle S, Cohen R, Guliana JM, Delehaye MC, Segond N, Calmettes C, Milhaud G, Moukhtar MS. Lasmoles F, et al. Among authors: guliana jm. FEBS Lett. 1990 Dec 17;277(1-2):243-6. doi: 10.1016/0014-5793(90)80856-e. FEBS Lett. 1990. PMID: 2269360 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters